SE8304920D0 - Novel pharmacological compositions based on cisplatinum and method for obtaining same - Google Patents
Novel pharmacological compositions based on cisplatinum and method for obtaining sameInfo
- Publication number
- SE8304920D0 SE8304920D0 SE8304920A SE8304920A SE8304920D0 SE 8304920 D0 SE8304920 D0 SE 8304920D0 SE 8304920 A SE8304920 A SE 8304920A SE 8304920 A SE8304920 A SE 8304920A SE 8304920 D0 SE8304920 D0 SE 8304920D0
- Authority
- SE
- Sweden
- Prior art keywords
- freeze
- cisplatinum
- drying
- dried
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT23396/82A IT1153974B (it) | 1982-09-23 | 1982-09-23 | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8304920D0 true SE8304920D0 (sv) | 1983-09-13 |
SE8304920L SE8304920L (sv) | 1984-03-24 |
SE464061B SE464061B (sv) | 1991-03-04 |
Family
ID=11206716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8304920A SE464061B (sv) | 1982-09-23 | 1983-09-13 | Framstaellning av stabil, frystorkad cis-platina(ii)-diammindiklorid ur en vatten-alkoholloesning |
Country Status (20)
Country | Link |
---|---|
US (1) | US4670262A (sv) |
JP (1) | JPS5978117A (sv) |
AT (1) | AT382077B (sv) |
AU (1) | AU559499B2 (sv) |
BE (1) | BE897761A (sv) |
CA (1) | CA1211372A (sv) |
CH (1) | CH655852A5 (sv) |
DE (1) | DE3333024A1 (sv) |
DK (1) | DK157168C (sv) |
FI (1) | FI78236C (sv) |
FR (1) | FR2533439B1 (sv) |
GB (1) | GB2127291B (sv) |
GR (1) | GR79055B (sv) |
IE (1) | IE56173B1 (sv) |
IL (1) | IL69752A (sv) |
IT (1) | IT1153974B (sv) |
NL (1) | NL8303211A (sv) |
SE (1) | SE464061B (sv) |
SU (1) | SU1424722A3 (sv) |
ZA (1) | ZA836904B (sv) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
IL76889A0 (en) * | 1984-11-02 | 1986-02-28 | Johnson Matthey Plc | Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same |
JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
JP2524217B2 (ja) * | 1988-04-18 | 1996-08-14 | マルハ株式会社 | 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤 |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
US20030148933A1 (en) * | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
CA2122342A1 (en) * | 1992-09-04 | 1994-03-17 | Hironori Kawabata | Pharmaceutical composition |
FR2759293B1 (fr) * | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
ATE363910T1 (de) * | 1999-11-15 | 2007-06-15 | Pharma Mar Sa | Behandlung von krebserkrankungen durch aplidin |
UA76718C2 (uk) * | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
BR0114604A (pt) * | 2000-10-12 | 2003-10-14 | Pharma Mar Sa | Tratamento de cnceres |
AU2002243646B2 (en) | 2001-01-25 | 2006-06-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Formulation of boronic acid compounds |
WO2003026642A1 (fr) * | 2001-09-21 | 2003-04-03 | Sumitomo Pharmaceuticals Co., Ltd. | Preparation pharmaceutique lyophilisee |
PT1435991E (pt) * | 2001-10-19 | 2009-01-16 | Pharma Mar Sa | Utilização de aplidina para o tratamento de cancro pancreático |
KR20060002778A (ko) * | 2003-03-12 | 2006-01-09 | 파르마 마르, 에스.에이. | 개선된 항종양 치료 |
AU2004218883B2 (en) * | 2003-03-12 | 2009-10-01 | Dana-Farber Cancer Institute, Inc. | Aplidine for multiple myeloma treatment |
DE50305909D1 (de) * | 2003-10-13 | 2007-01-18 | Salama Zoser B | Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze |
US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
ES2575518T3 (es) * | 2006-02-28 | 2016-06-29 | Pharma Mar S.A. | Tratamiento mejorado de mieloma múltiple |
AU2008313627A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
CN101965191A (zh) * | 2008-03-07 | 2011-02-02 | 法马马有限公司 | 改善的抗癌治疗 |
AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
CA2735899A1 (en) * | 2008-09-25 | 2010-04-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
CN107773538B (zh) * | 2016-08-27 | 2022-09-13 | 鲁南制药集团股份有限公司 | 稳定的甲啶铂无菌冻干粉末及其制备工艺 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1432563A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum- co-ordination compounds |
GB1432562A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
US4053587A (en) * | 1973-04-13 | 1977-10-11 | Research Corporation | Method of treating viral infections |
US4255417A (en) * | 1976-08-04 | 1981-03-10 | Johnson Matthey, Inc. | Platinum compounds for the irradication of skin blemishes |
SE445172B (sv) * | 1978-05-30 | 1986-06-09 | Bristol Myers Co | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform |
US4273755A (en) * | 1979-08-16 | 1981-06-16 | Mpd Technology Corporation | Preparation of platinum complexes |
US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
US4451447A (en) * | 1980-03-31 | 1984-05-29 | Bristol-Myers Company | Pharmaceutical formulations |
CA1162479A (en) * | 1980-03-31 | 1984-02-21 | Murray A. Kaplan | Pharmaceutical formulations containing cisplatin |
-
1982
- 1982-09-23 IT IT23396/82A patent/IT1153974B/it active
-
1983
- 1983-09-12 GB GB08324380A patent/GB2127291B/en not_active Expired
- 1983-09-13 SE SE8304920A patent/SE464061B/sv not_active IP Right Cessation
- 1983-09-13 AT AT0326283A patent/AT382077B/de active
- 1983-09-13 AU AU19089/83A patent/AU559499B2/en not_active Ceased
- 1983-09-13 DE DE3333024A patent/DE3333024A1/de not_active Withdrawn
- 1983-09-14 JP JP58168513A patent/JPS5978117A/ja active Pending
- 1983-09-15 SU SU833643499A patent/SU1424722A3/ru active
- 1983-09-15 GR GR72452A patent/GR79055B/el unknown
- 1983-09-15 FI FI833300A patent/FI78236C/sv not_active IP Right Cessation
- 1983-09-15 CH CH5037/83A patent/CH655852A5/de not_active IP Right Cessation
- 1983-09-15 BE BE0/211538A patent/BE897761A/fr not_active IP Right Cessation
- 1983-09-16 ZA ZA836904A patent/ZA836904B/xx unknown
- 1983-09-16 FR FR8314772A patent/FR2533439B1/fr not_active Expired
- 1983-09-16 DK DK424383A patent/DK157168C/da not_active IP Right Cessation
- 1983-09-16 IE IE2172/83A patent/IE56173B1/en unknown
- 1983-09-16 NL NL8303211A patent/NL8303211A/nl not_active Application Discontinuation
- 1983-09-16 IL IL69752A patent/IL69752A/xx unknown
- 1983-09-20 CA CA000437117A patent/CA1211372A/en not_active Expired
-
1985
- 1985-05-28 US US06/738,436 patent/US4670262A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
SU1424722A3 (ru) | 1988-09-15 |
US4670262A (en) | 1987-06-02 |
IT8223396A0 (it) | 1982-09-23 |
NL8303211A (nl) | 1984-04-16 |
GB2127291B (en) | 1986-01-15 |
IT1153974B (it) | 1987-01-21 |
FR2533439B1 (fr) | 1986-08-14 |
AT382077B (de) | 1987-01-12 |
FI833300A0 (fi) | 1983-09-15 |
BE897761A (fr) | 1984-01-02 |
FI78236B (fi) | 1989-03-31 |
IL69752A (en) | 1986-07-31 |
DK424383D0 (da) | 1983-09-16 |
AU559499B2 (en) | 1987-03-12 |
ZA836904B (en) | 1984-10-31 |
GB2127291A (en) | 1984-04-11 |
IL69752A0 (en) | 1983-12-30 |
FR2533439A1 (fr) | 1984-03-30 |
ATA326283A (de) | 1986-06-15 |
GB8324380D0 (en) | 1983-10-12 |
FI78236C (sv) | 1989-07-10 |
SE8304920L (sv) | 1984-03-24 |
IE56173B1 (en) | 1991-05-08 |
SE464061B (sv) | 1991-03-04 |
JPS5978117A (ja) | 1984-05-04 |
DK157168B (da) | 1989-11-20 |
DK157168C (da) | 1990-04-09 |
CA1211372A (en) | 1986-09-16 |
IE832172L (en) | 1984-03-23 |
DE3333024A1 (de) | 1984-03-29 |
DK424383A (da) | 1984-03-24 |
AU1908983A (en) | 1984-03-29 |
CH655852A5 (de) | 1986-05-30 |
FI833300A (fi) | 1984-03-24 |
GR79055B (sv) | 1984-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8304920D0 (sv) | Novel pharmacological compositions based on cisplatinum and method for obtaining same | |
DE3688114D1 (de) | Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate. | |
ES2082755T3 (es) | Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios. | |
NO885213D0 (no) | Stabiliserte legemidler, fremgangsmte til deres fremstilling samt stabile legemiddeltilberedninger. | |
NO164817C (no) | Fremgangsmaate til fremstilling av tofasede, nifedipinholdige, legemiddeltilberedninger. | |
HUT38263A (en) | Process for rendering active substances soluble and production of therapeutic compositions comprising these substances | |
CH549590A (fr) | Procede de preparation de derives d'acides pyrazolo (3,4b)pyridine-5-carboxyliques. | |
DK281184D0 (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling | |
NL7507268A (nl) | Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten. | |
PT87767A (pt) | Process for the manufacture of solid drug preparations containing micronized crystals of 2-phenyl-1,2-benzisoselenazol-3 (2h)-one (ebselen | |
ES8103972A1 (es) | Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina | |
IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
NO180473C (no) | Fremgangsmåte for fremstilling av et enteralt, farmasöytisk fôrpreparat for behandling av ektoparasittiske fiskesykdommer | |
NO179436C (no) | Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk | |
NL7416873A (nl) | Werkwijze ter bereiding van farmaceutische pre- en met anti-allergische werking, de aldus egen gevormde voortbrengselen, alsmede ijze ter bereiding van 5:6-benzo-gamma derivaten. | |
GB1363047A (en) | Pyrimidine derivative process for its preparation and its use as a medicament | |
NL165740C (nl) | Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire werking die as-triazinederivaten bevatten, verkregen gevormde preparaten, alsmede werk- wijze ter bereiding van de actieve as-triazine- derivaten. | |
ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. | |
CA960655A (en) | N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
AT342761B (de) | Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung | |
US3159650A (en) | Triethylenetetramine tetrascorbate and its preparation | |
HU901875D0 (en) | Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance | |
DE3375077D1 (en) | Galenic form of amitriptyloxide, and process for its preparation | |
GB2001995A (en) | An immunostimulant, a process for preparing it, and compositions containing it | |
HU172247B (hu) | Sposob poluchenija sinergeticheskogo lechebnogo preparata soderzhahhego 5-ftor-citozin i kandicidin ili trikhomicin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8304920-5 Effective date: 19940410 Format of ref document f/p: F |